AngioDynamics to Participate in Three Investor Conferences in March

AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology leader, announced participation in three investor conferences in March 2023.

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

conferences

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

02/28/2023 - 08:00 AM EST

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate in the following three investor conferences in March:

Raymond James Institutional Investors Conference
Format: In-person Presentation
Date: Monday, March 6, 2023
Time: 8:05 a.m. ET
Location: Orlando, FL

Oppenheimer Virtual Healthcare Conference
Format: Fireside Chat
Date: Monday, March 13, 2023
Time: 9:20 a.m. ET

KeyBanc Virtual Life Sciences & MedTech Investor Forum
Format: Fireside Chat
Date: Tuesday, March 21, 2023
Time: 4:30 p.m. ET

A live webcast of each presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following each event.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230228005538/en/

Investor:

AngioDynamics, Inc.
Stephen Trowbridge, Executive Vice President & CFO
(518) 795-1408

Source: AngioDynamics, Inc.

Keep reading

More on ANGO

All ANGO news

Trending in the feed

LWLG

Lightwave Logic, Inc. Electro-Optic Polymer Technology Integrated into Hon Hai Technology Group (Foxconn) Optical Transceiver Demonstrated at Hon Hai Tech Day Open the live feed